Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Genitourinary Drugs industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Genitourinary Drugs market can be split based on product types, major applications, and important countries as follows:
Key players in the global Genitourinary Drugs market covered in Chapter 12:
Rhone Poulenc Rorer Inc.
Agouron Pharmaceuticals Inc.
Pharmacia & John Inc
Hoffman-La Roche Inc.
Bristol-Myers Squibb Co.
Glaxo Wellcome Plc
Quadra Logic Technologies Inc.
Connaught Laboratories Inc.
Merck & Co.
Schering Plough Corp
In Chapter 4 and 14.1, on the basis of types, the Genitourinary Drugs market from 2015 to 2025 is primarily split into:
In Chapter 5 and 14.2, on the basis of applications, the Genitourinary Drugs market from 2015 to 2025 covers:
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
Europe (Covered in Chapter 8 and 14)
Asia-Pacific (Covered in Chapter 9 and 14)
Middle East and Africa (Covered in Chapter 10 and 14)
South America (Covered in Chapter 11 and 14)
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Contents
1 Genitourinary Drugs Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Genitourinary Drugs
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19’s impact on the Genitourinary Drugs industry
1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary
2.1 Market Overview
2.1.1 Global Genitourinary Drugs Market Size, 2015 – 2020
2.1.2 Global Genitourinary Drugs Market Size by Type, 2015 – 2020
2.1.3 Global Genitourinary Drugs Market Size by Application, 2015 – 2020
2.1.4 Global Genitourinary Drugs Market Size by Region, 2015 – 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Genitourinary Drugs Industry Development